rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
Clinical trial NCT02710500 · COMPLETED
Trial details
- NCT number
- NCT02710500
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-07-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.